FDA cites Daud’s Specialties, LLC in Lancaster for 4 violations during March 18 inspection

Sean R. Keveney J.D., Chief Counsel of FDA
Sean R. Keveney J.D., Chief Counsel of FDA
0Comments

During a March 18 inspection, Daud’s Specialties, LLC in Lancaster was cited for four violations by the Food and Drug Administration (FDA), according to data posted on the FDA’s website.

The inspection reviewed the company’s procedures in these areas:

  • Food Composition, Standards, Labeling and Econ
  • Foodborne Biological Hazards

The FDA records show that the issues cited included:

  • ‘You did not implement a process, allergen and sanitation preventive control.’
  • ‘You did not implement the monitoring, recordkeeping and verification procedures listed in your HACCP plan.’
  • ‘Your HACCP plan does not list verification procedures and frequencies that have been developed to ensure that the HACCP plan is adequate to control food safety hazards, and is being effectively implemented.’
  • ‘You are not maintaining sanitation control records that document monitoring and corrections of sanitation deficiencies for safety of water that comes into contact with food or food contact surfaces, including water used to manufacture ice, condition and cleanliness of food contact surfaces, prevention of cross-contamination from insanitary objects, maintenance of hand washing, hand sanitizing, and toilet facilities, protection of food, food packaging material, and food contact surfaces from adulteration, proper labeling, storage and use of toxic chemicals, control of employee health conditions and exclusion of pests.’

The FDA carries out routine inspections nationwide to assess if facilities and their products are in compliance with laws and regulations established to enhance public health. Inspection outcomes are made available to the public.

The agency’s website notes that the FDA is responsible for overseeing the safety and quality of drugs for humans and animals, biological products, medical supplies and tobacco products by monitoring their production and distribution.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Sridhar Mantha, Acting Chief Information Officer of FDA

FDA inspects Central Pennsylvania Blood Bank in Ephrata on March 11

The Central Pennsylvania Blood Bank in Ephrata was inspected by the FDA on March 11 regarding blood and blood product safety, based on information made available on the FDA’s website.

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

Companies across Lancaster County cities saw 4 FDA citations in March

There was one company in a city associated with Lancaster County that received FDA citations as a result of one inspection conducted in the county in March, according to reports from the U.S. Food and Drug Administration (FDA).

Jim Traficant, Chief of Staff of FDA

How many companies in cities in Lancaster County received FDA inspections in March?

There were two companies in cities associated with Lancaster County that received two FDA inspections in March, according to the U.S. Food and Drug Administration.